Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zyprexa Suit Appeal Rejected by High Court in Victory for Lilly
Bloomberg
Monday, June 27, 2011 - 10:39am
tags:
Zyprexa, Eli Lilly, schizophrenia
Icagen rockets 130% on Pfizer talks
Marketwatch
Monday, June 27, 2011 - 10:37am
tags:
Icagen, Pfizer, M&A
Life Technologies Ties Up with Pharma Majors
Yahoo/Zacks.com
Monday, June 27, 2011 - 10:36am
tags:
Life Technologies, AstraZeneca, Illumina, JNJ
It May Be Time to Throttle Back on Oncothyreon
Seeking Alpha
Monday, June 27, 2011 - 9:27am
tags:
Oncothyreon, Dendreon, ImmunoCellular, Merck KGaA
Watson Files More ANDAs
Yahoo/Zacks.com
Monday, June 27, 2011 - 9:22am
tags:
ANDAs, Watson Pharmaceuticals, GSK, Novartis, Pfizer, Adovart, nabumetone, Pataday
US Supreme Court throws out pharma data sales ban
Pharma Times, UK
Monday, June 27, 2011 - 9:00am
tags:
Supreme Court, data mining
Doing Deals With Biotechs Fails To Yield Results?
Pharmalot
Monday, June 27, 2011 - 8:55am
tags:
biotech
Dendreon: Key Catalysts in Play
Seeking Alpha
Monday, June 27, 2011 - 8:52am
tags:
Dendreon, prostate cancer, Provenge
FDA Appeals Panel to Hold Avastin Hearing This Week
WSJ Online
Monday, June 27, 2011 - 8:50am
tags:
FDA, Avastin, Roche, breast cancer
Collplant Jumps Most in 7 Months on Development With Pfizer
Bloomberg
Sunday, June 26, 2011 - 12:11pm
tags:
Collplant, Pfizer
Collplant, Pfizer Complete First Stage of Development Project
Bloomberg
Sunday, June 26, 2011 - 12:10pm
tags:
Collplant, Pfizer
Bristol-Myers, AstraZeneca Diabetes Drug Shows Bladder, Breast Cancer Risk
Bloomberg
Sunday, June 26, 2011 - 12:09pm
tags:
Bristol-Myers Squibb, AstraZeneca, Dapagliflozin, diabetes
Medicine's Next Revolution: 2 Cancer Vaccines With the Greatest Potential
Seeking Alpha
Sunday, June 26, 2011 - 12:03pm
tags:
Dendreon, prostate cancer, DN24-02, Neuvenge, Provenge, Oncothyreon, Stimuvax, colorectal cancer, breast cancer, Keryx
The Next Big Thing In Biotech: Dendreon
The Street
Sunday, June 26, 2011 - 11:59am
tags:
Dendreon
The 5 Companies in the Pharmaceuticals Industry With the Lowest P/E Ratio (SKBI, BSPM, DEPO, POZN, LLY)
Investor's Business Daily
Saturday, June 25, 2011 - 9:08pm
tags:
Skystar Bio-Pharmaceutical, Pozen, Biostar Pharmaceuticals, Depomed
AstraZeneca: Dividend Dynamo or Blowup?
Motley Fool
Saturday, June 25, 2011 - 8:59pm
tags:
AstraZeneca
Pfizer ponders 'strategic transaction' with Icagen
Yahoo/AP
Saturday, June 25, 2011 - 8:57pm
tags:
Pfizer, Icagen, M&A
Bristol-Myers Experimental Diabetes Drug Safe After 2 Years, Study Shows
Bloomberg
Saturday, June 25, 2011 - 8:44pm
tags:
Bristol-Myers Squibb, AstraZeneca
Positive Results for Investigational Compound Lyxumia (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions
Yahoo/PR NewsWire
Saturday, June 25, 2011 - 8:43pm
tags:
Lyxumia, diabetes, Sanofi
Two-Year Data Comparing Cardiovascular Events with Linagliptin and the Sulfonylurea, Glimepiride, Presented as Late-Breaking Poster at ADA
Yahoo/PR NewsWire
Saturday, June 25, 2011 - 8:42pm
tags:
linagliptin, sulfonylurea, glimepiride, diabetes, Boehringer Ingelheim, Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.